Aryl hydrocarbon receptor (AhR) agonists increase airway epithelial matrix metalloproteinase activity
详细信息 查看全文
- 作者：Ming-Ju Tsai (1) (2)
Ya-Lin Hsu (1)
Tsu-Nai Wang (3) (4)
Ling-Yu Wu (1)
Chi-Tun Lien (1) (2)
Chih-Hsing Hung (4) (5) (6)
Po-Lin Kuo (4) (7) (8)
Ming-Shyan Huang (1) (2) (9) - 关键词：Airway remodeling ; Aryl hydrocarbon receptor ; Asthma ; Chronic obstructive pulmonary disease ; Matrix metalloproteinase
- 刊名：Journal of Molecular Medicine
- 出版年：2014
- 出版时间：June 2014
- 年：2014
- 卷：92
- 期：6
- 页码：615-628
- 全文大小：
- 参考文献：1. Kung T, Murphy KA, White LA (2009) The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochem Pharmacol 77:536鈥?46 CrossRef
2. Dietrich C, Kaina B (2010) The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31:1319鈥?328 CrossRef
3. Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, Sicinski RR, DeLuca HF (2002) A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci U S A 99:14694鈥?4699 CrossRef
4. Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA (2006) A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem Biophys 450:67鈥?7 CrossRef
5. Tan Z, Chang X, Puga A, Xia Y (2002) Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem Pharmacol 64:771鈥?80 CrossRef
6. Wong PS, Vogel CF, Kokosinski K, Matsumura F (2010) Arylhydrocarbon receptor activation in NCI-H441 cells and C57BL/6 mice: possible mechanisms for lung dysfunction. Am J Respir Cell Mol Biol 42:210鈥?17 CrossRef
7. Carver LA, Hogenesch JB, Bradfield CA (1994) Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucleic Acids Res 22:3038鈥?044 CrossRef
8. Turner MC, Krewski D, Pope CA 3rd, Chen Y, Gapstur SM, Thun MJ (2011) Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med 184:1374鈥?381 CrossRef
9. Chiba T, Uchi H, Yasukawa F, Furue M (2011) Role of the arylhydrocarbon receptor in lung disease. Int Arch Allergy Immunol 155(Suppl 1):129鈥?34 CrossRef
10. Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, Mautino G, D鈥橝ccardi P, Bousquet J, Bonsignore G (1998) Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 158:1945鈥?950 CrossRef
11. Prikk K, Maisi P, Pirila E, Reintam MA, Salo T, Sorsa T, Sepper R (2002) Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest 82:1535鈥?545 CrossRef
12. Huang CD, Lin SM, Chang PJ, Liu WT, Wang CH, Liu CY, Lin HC, Hsieh LL, Kuo HP (2009) Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. J Asthma 46:41鈥?6 CrossRef
13. Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298:L715鈥揕731 CrossRef
14. Ohbayashi H (2002) Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3:409鈥?21 CrossRef
15. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M (2000) Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117:684鈥?94 CrossRef
16. Mercer BA, Wallace AM, Brinckerhoff CE, D鈥橝rmiento JM (2009) Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol 40:4鈥?2 CrossRef
17. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, D鈥橝rmiento J (2001) Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163:786鈥?91 CrossRef
18. Wygrecka M, Wilhelm J, Jablonska E, Zakrzewicz D, Preissner KT, Seeger W, Guenther A, Markart P (2011) Shedding of low-density lipoprotein receptor-related protein-1 in acute respiratory distress syndrome. Am J Respir Crit Care Med 184:438鈥?48 CrossRef
19. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, Suzuki R (1997) Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 155:43鈥?6 CrossRef
20. Martinez JM, Afshari CA, Bushel PR, Masuda A, Takahashi T, Walker NJ (2002) Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol Sci 69:409鈥?23 CrossRef
21. Wang TN, Lin MC, Wu CC, Leung SY, Huang MS, Chuang HY, Lee CH, Wu DC, Ho PS, Ko AM et al (2010) Risks of exposure to occupational asthmogens in atopic and nonatopic asthma: a case鈥揷ontrol study in Taiwan. Am J Respir Crit Care Med 182:1369鈥?376 CrossRef
22. Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart JM, Louis R (2000) MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123:259鈥?67 CrossRef
23. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269鈥?85 CrossRef
24. Volman TJ, Goris RJ, Lomme RM, DeGroot J, Verhofstad AA, Hendriks T (2004) Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome. J Pathol 203:968鈥?75 CrossRef
25. Puga A, Ma C, Marlowe JL (2009) The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77:713鈥?22 CrossRef
26. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, Shertzer HG (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54:1287鈥?296 CrossRef
27. Monteiro P, Gilot D, Le Ferrec E, Rauch C, Lagadic-Gossmann D, Fardel O (2008) Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol 73:769鈥?77 CrossRef
28. Chen S, Xu Y, Xu B, Guo M, Zhang Z, Liu L, Ma H, Chen Z, Luo Y, Huang S et al (2011) CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death. J Neurochem 119:1108鈥?118 CrossRef
29. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, Noel A, Louis R (2004) Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 84:418鈥?24 CrossRef
30. Villano CM, Murphy KA, Akintobi A, White LA (2006) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 210:212鈥?24 CrossRef
31. Murphy KA, Villano CM, Dorn R, White LA (2004) Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem 279:25284鈥?5293 CrossRef
32. Suzuki R, Kato T, Miyazaki Y, Iwata M, Noda Y, Takagi K, Nakashima N, Torii K (2001) Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma. J Asthma 38:477鈥?84 CrossRef
33. Kelly EA, Busse WW, Jarjour NN (2000) Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162:1157鈥?161 CrossRef
34. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S (2000) Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 105:900鈥?05 CrossRef
35. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ (2002) Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 122:1543鈥?552 CrossRef - 作者单位：Ming-Ju Tsai (1) (2)
Ya-Lin Hsu (1)
Tsu-Nai Wang (3) (4)
Ling-Yu Wu (1)
Chi-Tun Lien (1) (2)
Chih-Hsing Hung (4) (5) (6)
Po-Lin Kuo (4) (7) (8)
Ming-Shyan Huang (1) (2) (9)
1. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan
2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tz-You 1st Road, 807, Kaohsiung, Taiwan
3. Department of Public Health, College of Health Science, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan
4. Center of Excellence for Environmental Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan
5. Department of Pediatrics, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, No. 482, Shanming Rd, Hsiaogang District, 812, Kaohsiung, Taiwan
6. Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan
7. Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan
8. Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tz-You 1st Road, 807, Kaohsiung, Taiwan
9. Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, 807, Kaohsiung, Taiwan - ISSN：1432-1440
文摘